XML 45 R30.htm IDEA: XBRL DOCUMENT v3.2.0.727
Restructuring and Related Charges (Tables)
 9 Months Ended
Jun. 26, 2015
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring and Related Charges by Segment
Net restructuring and related charges by segment were as follows:
 
Three Months Ended
 
Nine Months Ended
 
June 26,
2015
 
June 27,
2014
 
June 26,
2015
 
June 27,
2014
Specialty Brands
$
20.2

 
$
7.5

 
$
35.3

 
$
9.7

Specialty Generics
0.5

 
4.3

 
3.2

 
4.8

Global Medical Imaging
0.6

 
10.6

 
(6.5
)
 
37.2

Corporate
1.8

 
1.8

 
2.2

 
2.3

Restructuring and related charges, net
23.1

 
24.2

 
34.2

 
54.0

Less: accelerated depreciation
—

 
(0.4
)
 
(0.2
)
 
(0.5
)
Restructuring charges, net
$
23.1

 
$
23.8

 
$
34.0

 
$
53.5
Schedule of Net Restructuring and Related Charges
Net restructuring and related charges were comprised of the following:
 
Three Months Ended
 
Nine Months Ended
 
June 26,
2015
 
June 27,
2014
 
June 26,
2015
 
June 27,
2014
2013 Mallinckrodt Program
$
3.7

 
$
23.0

 
$
1.7

 
$
53.9

Acquisitions
19.7

 
—

 
32.8

 
—

Other
(0.3
)
 
1.2

 
(0.3
)
 
0.1

Total
23.1

 
24.2

 
34.2

 
54.0

Less: non-cash charges, including accelerated share-based compensation expense
(1.5
)
 
(0.4
)
 
(9.4
)
 
(3.1
)
Total charges expected to be settled in cash
$
21.6

 
$
23.8

 
$
24.8

 
$
50.9
Schedule of Restructuring Reserves by Type of Cost
The following table summarizes cash activity for restructuring reserves, substantially all of which are related to employee severance and benefits:
 
2013 Mallinckrodt Program
 
Acquisitions
 
Other
 
Total
Balance at September 26, 2014
$
26.6

 
$
7.9

 
$
0.4

 
$
34.9

Charges
9.9

 
24.8

 
—

 
34.7

Changes in estimate
(8.3
)
 
(1.3
)
 
(0.3
)
 
(9.9
)
Cash payments
(18.9
)
 
(13.3
)
 
(0.1
)
 
(32.3
)
Reclassifications (1)
(2.5
)
 
—

 
—

 
(2.5
)
Currency translation
(0.7
)
 
—

 
—

 
(0.7
)
Balance at June 26, 2015
$
6.1

 
$
18.1

 
$
—

 
$
24.2
Schedule of Restructuring Charges Incurred Cumulative to Date
Net restructuring and related charges, including associated asset impairments, incurred cumulative-to-date related to the 2013 Mallinckrodt Program were as follows:
Specialty Brands
$
3.7

Specialty Generics
14.4

Global Medical Imaging
65.0

Corporate
7.9

 
$
91.0